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Summary
Objective: Calpains are known as Ca2C-dependent intracellular neutral cysteine proteases. However, m-calpain is detected in synovial ﬂuid of
arthritic joints and is shown to possess the proteoglycanase activity in vitro. The mechanism of m-calpain release into the extracellular spaces
during arthritis has not yet been well characterized. In the present study, we have analyzed m-calpain release from cultured chondrocytes
stimulated by a proinﬂammatory cytokine, tumor necrosis factor-a (TNF-a). The effects of non-steroidal anti-inﬂammatory drugs (NSAIDs) on
m-calpain release were also examined.
Methods: Human chondrocytic HCS-2/8 cells were stimulated by TNF-a in the presence or absence of an NSAID. m-Calpain in the cells and
culture medium was quantiﬁed by Western blot analysis using an anti-m-calpain antibody. Western blots were subjected to densitometric
analysis and band intensities were determined.
Results: TNF-a (10 ng/ml) stimulated m-calpain release with transient increase in cellular m-calpain in HCS-2/8 cells. NSAIDs examined
(aspirin, loxoprofen-SRS, diclofenac sodium, indomethacin and NS398) inhibited m-calpain release and production of prostaglandin E2 (PGE2)
induced by 10 ng/ml TNF-a. Exogenously added PGE2 accelerated the release of m-calpain in response to a lower concentration of
TNF-a (1 ng/ml). AH6809, an EP1/2 antagonist, but not SC19220 (an EP1 antagonist), effectively inhibited TNF-a-induced m-calpain release.
In contrast, butaprost, an EP2 agonist, accelerated release of m-calpain by 1 ng/ml TNF-a.
Conclusions: These results suggest that TNF-a stimulates upregulation and release of m-calpain in chondrocytic HCS-2/8 cells, and that
stimulation of EP2-PGE2 receptor by produced PGE2 is deeply involved in this process.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
The destruction of articular cartilage is the most signiﬁcant
pathologic process in osteoarthritis (OA) and rheumatoid
arthritis (RA). This destruction results from a homeostatic
imbalance between synthesis and degradation of the matrix
in the cartilage. Tumor necrosis factor-a (TNF-a), one of the
major proinﬂammatory cytokines, has been detected in joint
ﬂuid during the development of joint inﬂammation1,2. TNF-
a is known to inhibit synthesis of aggrecan3 and cartilage-
speciﬁc collagen4 in cartilage, and to stimulate chondro-
cytes and synoviocytes to produce matrix metalloprotei-
nases (MMPs)5e7 which are the most frequently implicated
in the degradation of cartilage extracellular matrix (ECM).
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the proteoglycanase activity in vitro8,9. Calpains are
ubiquitous family of Ca2C-dependent neutral cysteine
proteases10. The two isoforms are classiﬁed according to
their Ca2C requirements: m-calpain and m-calpain require
micromolar and millimolar concentrations of Ca2C for
activation, respectively. Although these Ca2C-dependent
proteases are generally believed to function only in the
cytoplasm10,11, m-calpain has recently been detected in the
extracellular spaces of some kinds of tissues9,12e18. For
example, m-calpain, localized on platelet surface, cleaves
platelet surface glycoproteins12 and von Willebrand fac-
tor13. This protease, exteriorized from myoblasts, is capable
of cleaving the ﬁbronectineintegrin complexes at the time of
myoblast fusion14. m-Calpain is also found in the synovial
ﬂuid and intra-articular tissues, and its level is upregulated
in joints of OA and RA patients19e21 and experimental
arthritis model in mice22,23. These ﬁndings strongly suggest
the possibility that m-calpain present in extracellular spaces
in arthritic joints plays an important role in destruction of
ECM of cartilage in addition to MMPs. However, the
mechanisms of the release of m-calpain into the extracel-
lular spaces have not been studied in detail.5
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to the most frequently used drugs in OA and RA therapy.
Despite their therapeutic efﬁcacy in modulating pain and
inﬂammation, their inﬂuence on cartilage metabolism is still
under discussion24e28. Some NSAIDs have been shown to
exert unfavorable inﬂuence on the synthesis of proteogly-
can and collagen in articular cartilage24,25. In contrast,
recent studies have reported that various NSAIDs have
protective effects on the cartilage against arthritic dam-
ages26e28. For example, NSAIDs downregulated the pro-
duction of MMP-1, -3, -9 and -13 from chondrocytes26,27.
NSAIDs are also reported to protect chondrocytes from
staurosporin-induced apoptotic death28.
In the present study, we have examined the mechanism
of m-calpain release from chondrocytes during TNF-a-
mediated inﬂammation and also the effects of NSAIDs on
m-calpain release. A human cultured chondrocytic cell line,
HCS-2/8, was stimulated by TNF-a. The results obtained
show that m-calpain is upregulated and released into
culture medium in HCS-2/8 cells in response to 10 ng/ml
TNF-a. NSAIDs examined, aspirin, diclofenac sodium,
loxoprofen-SRS, indomethacin and NS398, inhibited TNF-
a-induced m-calpain release and production of prostaglan-
din E2 (PGE2). In contrast, PGE2 potentiated the release of
m-calpain in response to a low concentration (1 ng/ml) of
TNF-a, probably through EP2-PGE2 receptor. These results
suggest that m-calpain is released from chondrocytes
during inﬂammation caused by TNF-a and that PGE2 plays
an important role in the exteriorization of m-calpain.
Materials and methods
MATERIALS
Dulbecco’s modiﬁed Eagle’s medium (DMEM) and fetal
bovine serum (FBS) were purchased from Sigma (St. Louis,
MO). Penicillin/streptomycin was from Gibco BRL (Grand
Island, CA). Human recombinant TNF-a was from Genzyme
(Minneapolis, MN). NS398, a selective cyclooxygenase-2
(COX-2) inhibitor, and indomethacin were obtained from
Wako (Osaka, Japan). PGE2, SC-19220 (an EP1 antago-
nist29), AH-6809 (an EP1/2 antagonist29,30), butaprost (an
EP2 agonist31,32) and PGE2 enzyme immunoassay (EIA) kit
were from Cayman Chemical (Ann Arbor, MI). Antibody
against m-calpain was from Chemicon International (Te-
mecula, CA). Anti-rabbit immunoglobulin G (IgG) horserad-
ish peroxidase-coupled secondary antibody was from
Amersham Pharmacia Biotech (Buckinghamshire, UK).
The enhanced chemiluminescence (ECL) Western blot
detection system was from Life Science Products (Boston,
MA). The lactate dehydrogenase (LDH) assay kit was from
Kyokoku (Tokyo, Japan). DEAE-cellulose (DE52) was from
Whatman (Springﬁeld, England). Amicon Ultra-4 micro-
concentrator was from Millipore (Bedford, MA). Total nitric
oxide (NO) assay kit was from R&D Systems Inc.
(Minneapolis, MN). Aspirin, diclofenac sodium, and loxo-
profen-SRS (an active metabolite of loxoprofen sodium)
were provided from Sankyo (Tokyo, Japan). ONO-AE3-208
(an EP4 antagonist33) and ONO-AE3-240 (an EP3 antag-
onist34) were gifts from Ono Pharmaceutical (Osaka,
Japan). All other reagents used were of the highest
analytical grade available.
CHONDROCYTE CULTURE AND STIMULATION
HCS-2/8 cells isolated from chondrosarcoma have
chondrocytic characters with production of type II collagenand aggrecan35. HCS-2/8 cells were cultured in DMEM
containing 10% FBS, penicillin (100 U/ml) and streptomycin
(100 mg/ml). The cells were cultured at a density of
2.5! 104/cm2 in 100-mm culture dishes in a humidiﬁed
atmosphere containing 5% CO2 at 37(C. Cells were
cultured for 3 days in complete DMEM and then incubated
in 2% FBSeDMEM for 24 h prior to stimulation with TNF-a.
NSAID, such as aspirin, diclofenac sodium, loxoprofen-
SRS, indomethacin and NS398, were dissolved in dimethyl
sulfoxide (DMSO). The ﬁnal DMSO concentration was
0.1%. If necessary, PGE2 and prostaglandin-receptor
agonists or antagonists were added 1 h before administra-
tion of TNF-a.
PREPARATION OF M-CALPAIN SAMPLES FROM THE MEDIUM
m-Calpain in the culture medium was puriﬁed by DEAE-
cellulose chromatography as previously described9,36. The
medium was collected, and centrifuged at 1000 g for 10 min
and then further at 10,000 g for 30 min at 4(C. The resulting
supernatants were applied to a DEAE-cellulose column
(1.5 ml) that had previously been equilibrated with the buffer
A (50 mM TriseHCl, pH 7.5, 50 mM NaCl, 1 mM EDTA,
1 mM EGTA and 5 mM 2-mercaptoethanol). The columns
were washed several times with the buffer A containing
200 mM NaCl, and then the protein was eluted with 4 ml
buffer A containing 400 mM NaCl. Finally, the eluents were
desalted and concentrated by 40-fold using Amicon Ultra-4
microconcentrator.
PREPARATION OF CELLULAR PROTEINS
Total cellular protein was prepared by lysing cells in lysis
buffer (50 mM TriseHCl, pH 7.5, 1 mM EDTA, 1 mM EGTA,
1% Triton X-100 and 5 mM 2-mercaptoethanol). The cells
were sonicated three times for 30 s on ice. After centrifu-
gation at 2000 g for 10 min, the supernatants were used as
cell lysates.
WESTERN BLOT ANALYSIS
The proteins were separated by polyacrylamide slab gel
electrophoresis (PAGE) in the presence of 0.1% sodium
dodecyl sulfate (SDS) with 7.5% resolving and 3% stacking
gels. After gel electrophoresis, proteins were transferred
onto PVDF membranes. Membranes were ﬁrst incubated
with anti-m-calpain antibody and then with secondary
antibody. Detection was performed with ECL system.
CELL VIABILITY
The release of LDH into the culture medium was
measured to monitor the rate of cellular breakdown. The
harvested culture medium was centrifuged at 1000 g for
10 min at 4(C to remove containing cells. LDH activity in
the resulting supernatant was determined spectrophoto-
metrically using an LDH assay kit.
EIA ASSAY FOR PGE2
Amount of PGE2 in culture medium was measured using
a commercial EIA kit. Cells in 60-mm dishes were incubated
with 10 ng/ml TNF-a, if necessary, in the presence of an
NSAID, for 24 h in 2.0 ml 2% FBSeDMEM. The harvested
culture medium was centrifuged at 1000 g for 10 min at
4(C. Aliquot of culture medium was assayed in triplicate.
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The NO produced was oxidized to its stable oxidative
products, nitrite and nitrate. The amounts of these stable
oxidative products were determined by the Griess re-
action37 using commercial NO assay kit. The cells were
inoculated into 60-mm culture dishes. After 24 h preincu-
bation with 2% FBSeDMEM, the culture medium was
replaced with 2% FBSeDMEM containing 10 ng/ml TNF-
a and then incubated for 24 h. The medium was collected,
and centrifuged at 1000 g for 10 min and then further
at 10,000 g for 30 min at 4(C. For NO assay, the proteins
in the resulting supernatants were removed using
a 10,000 MW cutoff ﬁlter.
STATISTICAL ANALYSIS
MeansG SD data were compared using Student’s t test,
with P values !0.05 taken as signiﬁcant.
Results
TNF-a STIMULATED UPREGULATION AND RELEASE
OF M-CALPAIN INTO THE CULTURE MEDIUM
We found the appearance of m-calpain in the medium of
primary cultured human cartilage specimens obtained from
patients with OA undergoing total knee joint replacement.
However, the amount of m-calpain found in the culture
medium extensively varied from specimen to specimen
(data not shown), probably due to individual variation
(severity of OA, age and so on). Therefore, the mechanism
of the appearance of m-calpain in the culture medium was
analyzed in the cloned human chondrocyte-like HCS-2/8
cells. The small amount of m-calpain, as assessed by
Western blotting, was found in the medium of non-treated
control cells. The level of m-calpain in the culture medium
was increased in response to a proinﬂammatory cytokine
TNF-a (Fig. 1). At 50 ng/ml TNF-a the increase of m-calpain
in the culture medium was accompanied with LDH release
(about 40% of total LDH at 48 h) and cleavage of poly
(ADP-ribose) polymerase (PARP), a maker of apoptotic cell
death (data not shown). Therefore, a part of released m-
calpain was derived passively from apoptotic cells. How-
ever, its signiﬁcant increase was observed in the culture
medium at 48 h after stimulation with TNF-a at a concen-
tration as low as 1 ng/ml, which did not stimulate the release
of LDH, a cell damage marker (Table I). At 10 ng/ml TNF-
a the level of m-calpain in the culture medium at 48 h
reached about 20-fold over that of unstimulated control
cells; the increase of which far exceeded that of LDH
release (nearly two-fold increase at 48 h after stimulation).
The m-calpain release by 10 ng/ml TNF-a was accompa-
nied by its transient increase in the cells [Fig. 1(C)]. TNF-a
(1 ng/ml) tended to increase cellular calpain, but not
signiﬁcantly by statistical analysis, at 36 h. These results
may suggest the induction of m-calpain and the active
release from the cells.
NSAIDS INHIBITED TNF-a-INDUCED M-CALPAIN RELEASE
NSAIDs are most frequently used in OA and RA therapy
and are shown to downregulate the production of MMPs
from chondrocytes26,27. Therefore, the effects of NSAIDs
(aspirin, diclofenac sodium, loxoprofen-SRS and NS398) on
the release of m-calpain induced by 10 ng/ml TNF-a were
further investigated. These drugs had no effects on thelevels of m-calpain in unstimulated control HCS-2/8 cells
and in their culture medium (data not shown). Moreover,
these drugs did not affect the leakage of small amount of
LDH from TNF-a-treated HCS-2/8 cells (Table I). On the
other hand, as shown in Fig. 2, TNF-a-induced release of
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Fig. 1. Effect of TNF-a on the cellular and extracellular levels of
m-calpain in HCS-2/8 cells. HCS-2/8 cells were treated without
(open column; B,C) or with 1 (hatched column; B,C) or 10 ng/ml
(ﬁlled column; B,C) TNF-a for the indicated periods of time.
Samples were subjected to Western blot analysis using an anti-m-
calpain antibody. (A) Typical Western blots of cells treated without
or with 10 ng/ml TNF-a. Four other independent experiments gave
similar results. (B) Densitometric quantiﬁcation of m-calpain in the
culture medium from Western blots. The results shown are fold
increase over control at 24 h. (C) Densitometric quantiﬁcation of
intracellular m-calpain. The m-calpain level in the cells at 0 h was
designed as 100%. The results are expressed as meansG SD of
ﬁve independent experiments. *P! 0.05, **P! 0.01 compared
with corresponding values for non-treated control cells.
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aspirin, diclofenac sodium, loxoprofen-SRS and NS398
concentration-dependently. Indomethacin (1e10 mM), at
concentrations which effectively inhibited the activities of
COXs38, also suppressed m-calpain release (data not
shown). Signiﬁcant inhibitory effects were observed for
aspirin at 100 mM (PZ 0.0253), loxoprofen-SRS at 10 mM
(PZ 0.0274) and diclofenac sodium at 10 mM
(PZ 0.0131). Among the NSAIDs examined, NS398,
known as a selective COX-2 inhibitor, blocked m-calpain
release in the lowest concentration (0.1 mM), with 41%
inhibition (PZ 0.0106). Transient increase of intracellular
m-calpain seen at 24 h after stimulation with 10 ng/ml TNF-
a was also signiﬁcantly downregulated by aspirin, diclofe-
nac sodium, loxoprofen-SRS and NS398, at concentrations,
which effectively suppressed external release (Fig. 3). In
order to conﬁrm that the effects of NSAIDs are reversible or
not, HCS-2/8 cells were ﬁrst incubated for 12 h with 10 ng/ml
TNF-a in the presence of an NSAID, loxoprofen-SRS
(10 mM), washed three times with fresh medium, and then
incubated with TNF-a for another 36 h in the absence or
presence of the drug. The inhibition of m-calpain release in
the cells treated with loxoprofen-SRS only for the ﬁrst 12 h
was almost comparable to that in the cells treated with the
drug for 48 h (Fig. 4). These results suggest that NSAIDs
exert their effects at early stage following TNF-a stimulation,
and that their effects were irreversible.
INVOLVEMENT OF PGE2 IN TNF-a-STIMULATED
M-CALPAIN RELEASE
NSAIDs usually exert their effects by the inhibition of
COX, a key enzyme that converts arachidonic acid to PG38.
In fact, NSAIDs tested almost abolished TNF-a-mediated
production of PGE2 (Table II), the most abundantly pro-
duced PG in skeletal tissues. Therefore, the involvement
of PGE2 in TNF-a-induced upregulation and release of
m-calpain was further investigated (Fig. 5). PGE2 alone
upto 1 mM had no effect on m-calpain release. PGE2 did not
further stimulate m-calpain release by TNF-a at 10 ng/ml,
Table I
Effects of TNF-a and NSAIDs on viability of HCS2/8 cells
Additions LDH release (% of total LDH)
Control 10.03G 0.30
TNF-a 1 ng/ml 10.25G 0.23
TNF-a 10 ng/ml 22.85G 0.53
C Aspirin
10 mM 22.28G 0.45
100 mM 21.58G 0.98
C Diclofenac
10 mM 18.10G 0.23
100 mM 20.73G 0.30
C Loxoprofen
10 mM 19.93G 0.45
100 mM 23.78G 0.30
C NS398
1 mM 18.46G 0.15
10 mM 22.02G 0.16
HCS2/8 cells in 100 mm dishes were incubated with TNF-a in the
presence of the indicated NSAIDs for 48 h. LDH release into the
culture medium was measured. Released LDH activity is expressed
as a percent of total LDH (medium plus cells). Data are
meansGSD from three dishes. Three independent experiments
were reproducible, and the typical data are represented.a concentration used in the previous experiments. How-
ever, PGE2 enhanced release into the culture medium and
transient increase in the cells of m-calpain stimulated
by a lower concentration of TNF-a (1 ng/ml). Moreover,
inhibition of m-calpain release by an NSAID, loxoprofen-
SRS, was signiﬁcantly reversed by 100 nM PGE2 (Fig. 4).
PGE2 exerts its effects through the interaction with
speciﬁc cell surface receptors39, which consist of four
subtypes, EP1e4. SC-19220 (a selective EP1 antago-
nist29), ONO-AE3-240 (a selective EP3 antagonist34) and
ONO-AE3-208 (a selective EP4 antagonist33) did not show
any inhibitory effects on TNF-a-induced upregulation
of m-calpain (Fig. 6). However, an EP1/2-antagonist,
AH680929,30 did inhibit TNF-a-stimulated m-calpain release
and its transient increase in the cells. On the other hand,
butaprost (an EP2 agonist31,32) accelerated m-calpain
release into the culture medium stimulated by 1 ng/ml
TNF-a. These results collectively suggest that PGE2, via
EP2 receptor, takes an important part in upregulation and
external release of m-calpain in chondrocytic HCS-2/8 cells
in response to TNF-a.
The possible involvement of NO in the production of
PGE2 via the induction of COX-2 has been recently
reported in human OA chondrocytes40 and rat osteo-
blasts41. TNF-a did stimulate the production of NO in
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Fig. 2. Inhibitory effects of NSAIDs on the release of m-calpain into
the culture medium. HCS-2/8 cells were stimulated with 10 ng/ml
TNF-a for 48 h in the presence of aspirin [Asp], loxoprofen-SRS
[Lox], diclofenac sodium [Dic] or NS398 [NS]. The culture medium
was subjected to Western blot analysis. Amount of m-calpain was
determined by densitometric quantiﬁcation from Western blots. The
results shown are inhibitory percent by taking the samples treated
with TNF-a alone as 0% and non-treated control cells as 100%.
Values are expressed as meansGSD of ﬁve independent experi-
ments. *P! 0.05 compared with corresponding values for the cells
treated with TNF-a alone.
899Osteoarthritis and Cartilage Vol. 12, No. 11[Asp] [Dic] [Lox] [NS]
5 4 5 4 5 4 6 5
TNFα -
NSAIDs (-log[M])
Cell
m-Calpain
Actin
(100) 0 75.2 97.5 93.4 93.9 98.2 98.6 97.1 99.0Inhibition(%)
+ + + + + + + + +
Fig. 3. NSAIDs suppressed TNF-a-induced expression of m-calpain in HCS-2/8 cells. HCS-2/8 cells were incubated without or with the
indicated NSAID (Asp; aspirin, Dic; diclofenac sodium, Lox; loxoprofen-SRS and NS; NS398) for 24 h in the presence of 10 ng/ml TNF-a.
Cellular proteins were subjected to Western blot analysis with anti-m-calpain antibody. Three independent experiments were reproducible, and
typical data are shown.HCS-2/8 cells (Fig. 7). Blockage of PGE2 production by
aspirin or loxoprofen-SRS had no effects on TNF-a-induced
NO production, suggesting that NO located at upstream of
PGE2 production.
Discussion
Cartilage destruction in OA and RA is characterized by
degradation of cartilage ECM. This degradation is generally
considered irreversible. Accordingly, drugs that inhibit the
destruction of cartilage ECM will be of therapeutic value.
MMPs are the most frequently implicated in the degradation
of cartilage ECM5e7. However, m-calpain, which is detected
in the synovial ﬂuid and intra-articular tissues of RA and OA
patients19e21,36, possesses the strong proteoglycanase
activity in vitro8,9. Although calpains are generally believed
to function only in the cytoplasm10, m-calpain has recently
been detected in the extracellular spaces9,12e23 and is
implicated in physiological functions such as myoblast
migration14 and blood coagulation12,13. These results
suggest that m-calpain could be externally released from
synoviocytes and chondrocytes during arthritis and plays
a role in degradation of cartilage ECM. However, the
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Fig. 4. Reversibility of the effect of loxoprofen-SRS. HCS-2/8 cells
were ﬁrst incubated with 10 ng/ml TNF-a for 12 h in the presence of
10 mM loxoprofen-SRS. The culture medium was removed and the
cells were washed three times with fresh medium. Then, the cells
were incubated with TNF-a for another 36 h in the presence
(indicated as 48 h) or absence (indicated as 12 h) of the drug. If
necessary, 100 nM PGE2 was included in the culture medium. The
culture medium was subjected to Western blot analysis. Amount of
m-calpain was determined by densitometric quantiﬁcation from
Western blots. Three independent experiments were reproducible,
and typical data are shown.mechanisms of the release of m-calpain into the extracellular
spaces during arthritis have yet been poorly understood.
In the present study, we have demonstrated the release of
m-calpain into the culture medium from HCS-2/8 chondro-
cytic cells stimulated by a proinﬂammatory cytokine, TNF-a.
TNF-a (50 ng/ml) stimulatedm-calpain release and apoptotic
cell death, indicating that a part of released m-calpain was
derived passively from apoptotic cells. TNF-a at 1 ng/ml
stimulated the release of m-calpain without induction of LDH
leakage. The increase of m-calpain (10e20 fold) induced by
10 ng/ml TNF-a in the culture medium far exceeded that of
LDH (w2 fold), a cell damagemarker. Although NSAIDs had
no effects on LDH release (Table I), m-calpain release was
suppressed by these drugs. Therefore, the increase of
m-calpain in the culture mediumwas not due to the damaged
passive leakage like LDH, but due to active release from the
cell, as reported previously in several types of cells12e14,18.
m-Calpain does not have a signal peptide sequence, which is
requisite for entering the classical secretory pathway.
However, several proteins without a signal peptide sequence
such as interleukine-1a/b and ﬁbroblast growth factor (FGF)
are secreted via as-yet unidentiﬁed mechanism42,43. The
vesicle-mediated secretion of m-calpain was proposed in
MC3T3-E1 osteoblastic cell line18. The extracellular release
of m-calpain was associated with transient increase (at 24 h
after TNF-a stimulation) of its intracellular level. These
Table II
Inhibitory effects of NSAIDs on TNF-a-induced PGE2 production
Additions PGE2 production
(pg/mg cellular protein)
Control 9.51G 0.38
TNF-a 10 ng/ml 17.28G 0.72
C Aspirin 9.57G 0.09*
C Diclofenac 9.64G 0.06*
C Loxoprofen 9.63G 0.19*
C NS398 9.50G 0.11*
HCS2/8 cells in 60 mm dishes were incubated with TNF-a in the
presence of 100 mM aspirin or 10 mM other NSAIDs (diclofenac,
loxoprofen-SRS or NS398) for 24 h. PGE2 in the culture medium
was determined by EIA. Data are meansGSD from three dishes.
Two independent experiments were reproducible.
*P! 0.05 compared with corresponding values for the cells
treated with 10 ng/ml TNF-a alone.
900 K. Fushimi et al.: m-Calpain release from chondrocytes by TNF-aresults suggest the induction of m-calpain and further
support the active release from the cell.
NSAIDs examined potently inhibited TNF-a-induced
release of m-calpain (Fig. 2). The therapeutic potencies
of NSAIDs are usually explained by their ability to inhibit
COX, thereby the production of PGs38,44. In fact, NSAIDs
examined almost abolished TNF-a-mediated production of
PGE2 in HCS-2/8 cells. Although aspirin, diclofenac sodium
and loxoprofen-SRS have low COX selectivity, NS398 is
a highly COX-2 selective inhibitor38. The strongest inhibition
by NS398 indicates that PG produced by induced COX-2
is closely involved in upregulation and external release
of m-calpain in TNF-a-stimulated HCS-2/8 cells. NO is
implicated in the production of PGE2 via the induction of
COX-2 in human OA chondrocytes40 and rat osteoblasts41.
TNF-a did stimulate the production of NO in HCS-2/8 cells
(Fig. 7). Therefore, NO may take part in TNF-a-stimulated
PGE2 production.
PGE2 alone failed to stimulate, but it signiﬁcantly
augmented the release of m-calpain in the presence of
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Fig. 5. Effect of PGE2 on the external release and cellular level of
m-calpain in HCS-2/8 cells. HCS-2/8 cells were incubated without
(B) or with 1 ng/ml TNF-a (C) or with 10 ng/ml TNF-a (O) in the
presence of the indicated concentrations of PGE2. Culture medium
was subjected to Western blot analysis. Densitometric quantiﬁca-
tion of m-calpain from Western blots of the culture medium (A) and
cell lysate (B). The results are expressed as meansG SD of four
independent experiments. *P! 0.05 compared with corresponding
values for the cells treated with 1 ng/ml TNF-a alone.1 ng/ml TNF-a in HCS-2/8 cells (Fig. 5). Moreover, inhibition
of m-calpain release by an NSAID, loxoprofen-SRS, was
signiﬁcantly reversed by 100 nM PGE2 (Fig. 4). Therefore,
PGE2 is involved in TNF-a-induced m-calpain release. The
actions of PGE2 are mediated by four distinct classes of
PGE2 E-prostanoid (EP) receptors, EP1e4
39. The present
data indicate that TNF-a-induced upregulation and release
of m-calpain in HCS-2/8 might be mediated by EP2-PGE2
receptor. PGE2 is involved in both the bone-forming
45 and
bone-resorbing46 processes. PGE2 promotes the differen-
tiation and development of chondrocytes45,47. These
physiological responses are mediated by EP2 and/or EP4,
which increase the intracellular cAMP concentration39. The
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Fig. 6. Effects of prostanoid receptor antagonists and agonists on
the external release and cellular level of m-calpain in HCS-2/8 cells.
(A) HCS-2/8 cells were stimulated with 10 ng/ml TNF-a for 24 or
48 h in the presence of 10 mM AH6809 (EP1/2 antagonist), 10 mM
SC19220 (EP1 antagonist) or 10 mM ONO-AE-208 (EP4 antago-
nist). The culture medium (incubated for 48 h) and cell lysate
(incubated for 24 h) were subjected to Western blot analysis. The
blots were subjected to densitometric analysis and band intensities
were determined. The results are expressed as meansG SD by
taking the samples treated with TNF-a alone as 100% and non-
treated control cells sample as 0%. (B) HCS-2/8 cells were
incubated without (B) or with (C) 1 ng/ml TNF-a in the presence
of the indicated concentrations of butaprost (EP2 agonist). The
culture medium was subjected to Western blot analysis. The blots
were subjected to densitometric analysis and band intensities were
determined. The results are expressed as meansG SD of four
independent experiments. * P! 0.05 compared with correspond-
ing values for the cells treated with TNF-a alone.
901Osteoarthritis and Cartilage Vol. 12, No. 11stimulation of EP2 and EP4 cooperatively enhance the
production of proteoglycan and type II collagen in growth
plate chondrocytes of rats45. Vitamin D-metabolite-induced
matrix maturation is shown to be mediated by EP2 receptor
in resting zone chondrocytes47. However, PGE2 is also
implicated in growth arrest and apoptosis of chondrocytes.
The anti-proliferative effect of IL-1 on articular chondrocytes
is shown to be mediated by the induction of PGE2
48. PGE2
has apoptotic activity in cultured chondrocytes from OA
joints40. PGE2-induced apoptosis in bovine articular chon-
drocyte appears to be mediated by c-AMP pathway49. In
TNF-a-stimulated chondrocytes, increased cAMP by EP2
receptor activation45,50 is involved in upregulation and/or
external release of m-calpain. Therefore, increased cAMP
may elicit a variety of physiological responses depending
on the cellular conditions. Further studies are necessary to
clarify the intracellular signals implicated in the upregulation
and external release of m-calpain.
In conclusion, we have disclosed that a proinﬂammatory
cytokine, TNF-a, induced upregulation and external release
of m-calpain in chondrocyte-like HCS-2/8 cells. Further-
more, EP2 receptor stimulation by produced PGE2, which
can be suppressed by NSAIDs, is deeply involved in this
process. These results provide new information about the
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Fig. 7. NO production in TNF-a-stimulated HCS-2/8 cells. (A) The
cells were incubated with 1 or 10 ng/ml TNF-a. (B) The cells were
incubated with 10 ng/ml TNF-a in the absence or presence of
10 mM aspirin (Asp) or 10 mM loxoprofen-SRS (Lox). The level of
NO in the medium was determined using commercial total NO
assay kit. The results are expressed as meansG SD of four
independent experiments.protective effects of NSAIDs on the degradation process of
cartilage ECM in arthritis pathology.
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